RxDoctor Payments Data

Mark Wang, MD

Orthopaedic Surgery of the Spine · Phoenix, AZNPI 1881806834

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (35.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Globus Medical accounts for 69.2% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2019 at $270,720 and has fallen 88.4% since, to $31,487 in 2025. Among orthopaedic surgery of the spine clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$573,478in general payments, 2019–2025

Across 646 payments — averaging $887.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$397K
  • Medacta USA, Inc.$93K
  • Integrity Implants Inc.$43K
  • Xtant Medical Inc$12K
  • Integrity Implants Inc. Dba Accelus$9K
  • Spine Wave, Inc.$7K
  • plus $12K from 30 others
$3,000in research payments, 2019–2025

Across 10 payments — averaging $300.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intrinsic Therapeutics$3K
$37,476in ownership & investment interests, 2019–2025

Across 7 payments — averaging $5353.74 each. An ownership or investment interest held by the physician or an immediate family member.

  • Amplify Surgical, Inc.$37K

What the payments were for

  • Royalty or licence$204,12136%
  • Consulting fees$149,12226%
  • Speaking & faculty fees$122,77521%
  • Travel & lodging$76,08213%
  • Food & beverage$21,0654%
  • Education$2400%
  • Gifts$440%
  • Entertainment$280%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$573,478 in reported general payments places this provider in the 90th percentile of 64 orthopaedic surgery of the spine providers in Arizona.

See all orthopaedic surgery of the spine providers in Arizona

Medicare billing

Part B allowed, 2024
$463,881
Medicare patients
578
Services billed
2,230

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen43$611
Gabapentin53$551
Methylprednisolone44$302
Oxycodone Hcl32$228
Cyclobenzaprine Hcl22$191
Diclofenac Sodium13$121
Tramadol Hcl24$115

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →